This application represents the completion of a three year process of consolidation of the University of Wisconsin's two National Cancer Institute Funded Cancer Centers. The McArdle Laboratory for Cancer Research Cancer Center Support Grant will complete 37 years of continuous support in April 2001 and The University of Wisconsin Comprehensive Cancer Center will complete 29 years of continuous support in April 2001. The newly consolidated and greatly expanded University of Wisconsin Comprehensive Cancer Center (UWCCC) is a comprehensive, multi-disciplinary, matrix research institute which supports and stimulates study of the basic biology of cancer, the translation of new discoveries to clinical application, and the study of the incidence and public health related issues of controlling what is the National's number one health problem. The ultimate goal of the faculty and staff of the UWCCC is the prevention and cure of cancer. The UWCCC is ultimate goal of the faculty and staff of the UWCCC is the prevention and cure of cancer The UWCCC is composed of 201 faculty members coming from 41 departments and nine different University schools. The faculty is supported in their work by more than 500 staff. The UWCCC is organized into eight collaborative research programs: Cancer Control and Population Sciences; Cancer Genetics; Cell Signaling and Growth Control; Etiology and Chemoprevention; Experimental Therapeutics; Human Cancer Virology; Imaging and Radiation Sciences; and Immunology and immunotherapy. Four of these programs have clinical trial activity and all eight closely interact with fourteen Disease Oriented Multi-disciplinary Working Groups. The present application proposes to continue support for the CCSGs of the two UW Centers as a newly merged and restructured University based comprehensive cancer center. This application requests renewal of comprehensive status and support for senior leaders, program leaders, staff investigators, planning and evaluation, developmental funds, administration, protocol data review and monitoring, support staff for phase I/II clinical trials, and fifteen shared services essential to facilitate and enhance the multi-disciplinary research of the UWCCC.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA014520-32S1
Application #
6941459
Study Section
Subcommittee G - Education (NCI)
Program Officer
Ciolino, Henry P
Project Start
1976-01-01
Project End
2006-03-31
Budget Start
2004-04-01
Budget End
2005-03-31
Support Year
32
Fiscal Year
2004
Total Cost
$247,043
Indirect Cost
Name
University of Wisconsin Madison
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Xu, Cheng; Chen, Feng; Valdovinos, Hector F et al. (2018) Bacteria-like mesoporous silica-coated gold nanorods for positron emission tomography and photoacoustic imaging-guided chemo-photothermal combined therapy. Biomaterials 165:56-65
Wargowski, Ellen; Johnson, Laura E; Eickhoff, Jens C et al. (2018) Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine. J Immunother Cancer 6:21
Bednarz, Bryan; Grudzinski, Joseph; Marsh, Ian et al. (2018) Murine-specific Internal Dosimetry for Preclinical Investigations of Imaging and Therapeutic Agents. Health Phys 114:450-459
Romero-Masters, James C; Ohashi, Makoto; Djavadian, Reza et al. (2018) An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. PLoS Pathog 14:e1007221
van den Broek, Jeroen J; van Ravesteyn, Nicolien T; Mandelblatt, Jeanne S et al. (2018) Comparing CISNET Breast Cancer Incidence and Mortality Predictions to Observed Clinical Trial Results of Mammography Screening from Ages 40 to 49. Med Decis Making 38:140S-150S
Lu, Zhanping; Hong, Courtney C; Kong, Guangyao et al. (2018) Polycomb Group Protein YY1 Is an Essential Regulator of Hematopoietic Stem Cell Quiescence. Cell Rep 22:1545-1559
Shea, Michael P; O'Leary, Kathleen A; Fakhraldeen, Saja A et al. (2018) Antiestrogen Therapy Increases Plasticity and Cancer Stemness of Prolactin-Induced ER?+ Mammary Carcinomas. Cancer Res 78:1672-1684
Schrager, Sarina; Burnside, Elizabeth (2018) Breast Cancer Screening in Primary Care: A Call for Development and Validation of Patient-Oriented Shared Decision-Making Tools. J Womens Health (Larchmt) :
Ehlerding, Emily B; Grodzinski, Piotr; Cai, Weibo et al. (2018) Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics. ACS Nano 12:2106-2121
Liu, Bai; Jones, Monica; Kong, Lin et al. (2018) Evaluation of the biological activities of the IL-15 superagonist complex, ALT-803, following intravenous versus subcutaneous administration in murine models. Cytokine 107:105-112

Showing the most recent 10 out of 1528 publications